Treatment of Wolff-Parkinson-White syndrome.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004562:Electrocardiography; D006321:Heart / Q000503:physiopathology; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D011433:Propranolol / Q000627:therapeutic use; D013610:Tachycardia / Q000209:etiology; D014672:Vectorcardiography; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D008012:Lidocaine; D011433:Propranolol